Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors.

The results presented in this basic research were found to be consistent with the clinical findings to date. The mechanism by which 30-50% of AT activity is set as the clinical boundary was elucidated by the thrombin generation assay.